The p53–Mdm2 module and the ubiquitin system

Michael, 2002, The p53 and Mdm2 families in cancer, Curr Opin Genet Dev, 12, 53, 10.1016/S0959-437X(01)00264-7

Bargonetti, 2002, Multiple roles of the tumor suppressor p53, Curr Opin Oncol, 14, 86, 10.1097/00001622-200201000-00015

Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675

Prives, 1999, The p53 pathway, J Pathol, 187, 112, 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3

Vousden, 2000, The ins and outs of p53, Nat Cell Biol, 2, E178, 10.1038/35036427

Woods, 2001, Regulation of p53 function, Exp Cell Res, 264, 56, 10.1006/excr.2000.5141

Vousden, 2000, p53: death star, Cell, 103, 691, 10.1016/S0092-8674(00)00171-9

Lassus, 1996, Anti-apoptotic activity of low levels of wild-type p53, EMBO J, 15, 4566, 10.1002/j.1460-2075.1996.tb00834.x

Raj, 2001, Virus-mediated killing of cells that lack p53 activity, Nature, 412, 914, 10.1038/35091082

Telerman, 1993, A model for tumor suppression using h-1 parvovirus, Proc Natl Acad Sci USA, 90, 8702, 10.1073/pnas.90.18.8702

Derry, 2001, C. elegans p53: role in apoptosis, meiosis, and stress resistance, Science, 13, 13

Barak, 1993, mdm2 expression is induced by wild type-p53 activity, EMBO J, 12, 461, 10.1002/j.1460-2075.1993.tb05678.x

Wu, 1993, The p53 mdm-2 autoreg-ulatory feedback loop, Genes Dev, 7, 1126, 10.1101/gad.7.7a.1126

Momand, 2000, MDM2–master regulator of the p53 tumor suppressor protein, Gene, 242, 15, 10.1016/S0378-1119(99)00487-4

Juven-Gershon, 1999, Mdm2: the ups and downs, Mol Med, 5, 71, 10.1007/BF03402141

Momand, 1992, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, 69, 1237, 10.1016/0092-8674(92)90644-R

Daujat, 2001, MDM2: life without p53, Trends Genet, 17, 459, 10.1016/S0168-9525(01)02369-1

Marechal, 1994, The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes, Mol Cell Biol, 14, 7414, 10.1128/MCB.14.11.7414

Elenbaas, 1996, The MDM2 oncoprotein binds specifically to RNA through its RING finger domain, Mol Med, 2, 439, 10.1007/BF03401903

Lohrum, 2000, Identification of a cryptic nucleolar-localization signal in MDM2, Nat Cell Biol, 2, 179, 10.1038/35004057

Kastan, 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res, 51, 6304

Maltzman, 1984, UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol Cell Biol, 4, 1689, 10.1128/MCB.4.9.1689

Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0

Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0

Maki, 1996, In vivo ubiquitination and proteasome-mediated degradation of p53, Cancer Res, 56, 2649

Chowdary, 1994, Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway, Mol Cell Biol, 14, 1997, 10.1128/MCB.14.3.1997

Honda, 1997, Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53, FEBS Lett, 420, 25, 10.1016/S0014-5793(97)01480-4

Scheffner, 1993, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53, Cell, 75, 495, 10.1016/0092-8674(93)90384-3

Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8

Huibregtse, 1995, A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase, Proc Natl Acad Sci USA, 92, 2563, 10.1073/pnas.92.7.2563

Jackson, 2000, The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases, Trends Cell Biol, 10, 429, 10.1016/S0962-8924(00)01834-1

de Rozieres, 2000, The loss of mdm2 induces p53-mediated apoptosis, Oncogene, 19, 1691, 10.1038/sj.onc.1203468

Jones, 1995, Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53, Nature, 378, 206, 10.1038/378206a0

Montes de Oca Luna, 1995, Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53, Nature, 378, 203, 10.1038/378203a0

Kubbutat, 1998, Regulation of Mdm2-directed degradation by the C terminus of p53, Mol Cell Biol, 18, 5690, 10.1128/MCB.18.10.5690

Rodriguez, 2000, Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation, Mol Cell Biol, 20, 8458, 10.1128/MCB.20.22.8458-8467.2000

Lohrum, 2001, C-terminal ubiquitination of p53 contributes to nuclear export, Mol Cell Biol, 21, 8521, 10.1128/MCB.21.24.8521-8532.2001

Maki, 1999, Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2, J Biol Chem, 274, 16531, 10.1074/jbc.274.23.16531

Thrower, 2000, Recognition of the polyubiquitin proteolytic signal, EMBO J, 19, 94, 10.1093/emboj/19.1.94

Ciechanover, 2000, Ubiquitin-mediated proteol-ysis: biological regulation via destruction, Bioessays, 22, 442, 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q

Lai, 2001, Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization, J Biol Chem, 276, 31357, 10.1074/jbc.M011517200

Giaccia, 1998, The complexity of p53 modulation: emerging patterns from divergent signals, Genes Dev, 12, 2973, 10.1101/gad.12.19.2973

Craig, 1999, Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers, Biochem J, 342, 133, 10.1042/0264-6021:3420133

Chehab, 1999, Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage, Proc Natl Acad Sci USA, 96, 13777, 10.1073/pnas.96.24.13777

Shieh, 1999, DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, ser20, requires tetramerization, EMBO J, 18, 1815, 10.1093/emboj/18.7.1815

Shieh, 1997, DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2, Cell, 91, 325, 10.1016/S0092-8674(00)80416-X

Unger, 1999, Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2, EMBO J, 18, 1805, 10.1093/emboj/18.7.1805

Siliciano, 1997, DNA damage induces phosphorylation of the amino terminus of p53, Genes Dev, 11, 3471, 10.1101/gad.11.24.3471

Ashcroft, 1999, Regulation of p53 function and stability by phosphorylation, Mol Cell Biol, 19, 1751, 10.1128/MCB.19.3.1751

Hengstermann, 1998, Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation, Oncogene, 17, 2933, 10.1038/sj.onc.1202282

Perry, 1993, The mdm-2 gene is induced in response to UV light in a p53-dependent manner, Proc Natl Acad Sci USA, 90, 11623, 10.1073/pnas.90.24.11623

Inoue, 2001, Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents, FEBS Lett, 490, 196, 10.1016/S0014-5793(01)02123-8

Ashcroft, 2000, Stress signals utilize multiple pathways to stabilize p53, Mol Cell Biol, 20, 3224, 10.1128/MCB.20.9.3224-3233.2000

Wang, 2002, p53 activation by nitric oxide involves down-regulation of Mdm2, J Biol Chem, 277, 15697, 10.1074/jbc.M112068200

Maya, 2001, ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage, Genes Dev, 15, 1067, 10.1101/gad.886901

de Toledo, 2000, ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation, Oncogene, 19, 6185, 10.1038/sj.onc.1204020

Mayo, 2001, A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus, Proc Natl Acad Sci USA, 98, 11598, 10.1073/pnas.181181198

Zhang, 2001, A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation, Science, 292, 1910, 10.1126/science.1058637

Zhou, 2001, HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation, Nat Cell Biol, 3, 973, 10.1038/ncb1101-973

Pomerantz, 1998, The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53, Cell, 92, 713, 10.1016/S0092-8674(00)81400-2

Zhang, 1998, ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell, 92, 725, 10.1016/S0092-8674(00)81401-4

Stott, 1998, The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2, EMBO J, 17, 5001, 10.1093/emboj/17.17.5001

Kamijo, 1998, Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2, Proc Natl Acad Sci USA, 95, 8292, 10.1073/pnas.95.14.8292

Honda, 1999, Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53, EMBO J, 18, 22, 10.1093/emboj/18.1.22

Midgley, 2000, An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo, Oncogene, 19, 2312, 10.1038/sj.onc.1203593

Xirodimas, 2001, Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo, Oncogene, 20, 4972, 10.1038/sj.onc.1204656

Sherr, 2000, The ARF/p53 pathway, Curr Opin Genet Dev, 10, 94, 10.1016/S0959-437X(99)00038-6

Tao, 1999, P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2, Proc Natl Acad Sci USA, 96, 6937, 10.1073/pnas.96.12.6937

Zhang, 1999, Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53, Mol Cell, 3, 579, 10.1016/S1097-2765(00)80351-2

Weber, 1999, Nucleolar Arf sequesters Mdm2 and activates p53, Nat Cell Biol, 1, 20, 10.1038/8991

Llanos, 2001, Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus, Nat Cell Biol, 3, 445, 10.1038/35074506

Lomax, 2001, Polyoma virus disrupts ARF signaling to p53, Oncogene, 20, 4951, 10.1038/sj.onc.1204717

Fang, 2000, Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53, J Biol Chem, 275, 8945, 10.1074/jbc.275.12.8945

Honda, 2000, Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase, Oncogene, 19, 1473, 10.1038/sj.onc.1203464

Chang, 1998, Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway, Cell Growth Differ, 9, 79

Buschmann, 2000, SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53, Cell, 101, 753, 10.1016/S0092-8674(00)80887-9

Tao, 1999, Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53, Proc Natl Acad Sci USA, 96, 3077, 10.1073/pnas.96.6.3077

Sharp, 1999, Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein, J Biol Chem, 274, 38189, 10.1074/jbc.274.53.38189

Stad, 2000, Hdmx stabilizes Mdm2 and p53, J Biol Chem, 275, 28039, 10.1074/jbc.M003496200

Stad, 2001, Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms, EMBO Rep, 17, 17

Wang, 2001, MDM2 and MDMX can interact differently with ARF and members of the p53 family, FEBS Lett, 490, 202, 10.1016/S0014-5793(01)02124-X

Parant, 2001, Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53, Nat Genet, 20, 20

Ruland, 2001, p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101, Proc Natl Acad Sci USA, 98, 1859, 10.1073/pnas.98.4.1859

Li, 2001, A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control, Proc Natl Acad Sci USA, 98, 1619, 10.1073/pnas.98.4.1619

Hsieh, 1999, RB regulates the stability and the apoptotic function of p53 via MDM2, Mol Cell, 3, 181, 10.1016/S1097-2765(00)80309-3

Buschmann, 2001, Stabilization and activation of p53 by the coactivator protein TAFII31, J Biol Chem, 276, 13852, 10.1074/jbc.M007955200

Sionov, 1999, c-Abl neutralizes the inhibitory effect of Mdm2 on p53, J Biol Chem, 274, 8371, 10.1074/jbc.274.13.8371

Argentini, 2001, The contribution of the acidic domain of MDM2 to p53 and MDM2 stability, Oncogene, 20, 1267, 10.1038/sj.onc.1204241

Zhu, 2001, Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis, J Biol Chem, 276, 29695, 10.1074/jbc.M102634200

Kubbutat, 1999, Analysis of the degradation function of Mdm2, Cell Growth Differ, 10, 87

Xie, 2000, Physical association of ubiquitin ligases and the 26S proteasome, Proc Natl Acad Sci USA, 97, 2497, 10.1073/pnas.060025497

Kleijnen, 2000, The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome, Mol Cell, 6, 409, 10.1016/S1097-2765(00)00040-X

Hay, 2000, Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains, FEBS Lett, 478, 183, 10.1016/S0014-5793(00)01850-0

Hjerrild, 2001, Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells, Biochem J, 355, 347, 10.1042/0264-6021:3550347

Shaulsky, 1991, Nuclear localization is essential for the activity of p53 protein, Oncogene, 6, 2055

Stommel, 1999, A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking, EMBO J, 18, 1660, 10.1093/emboj/18.6.1660

Roth, 1998, Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein, EMBO J, 17, 554, 10.1093/emboj/17.2.554

Geyer, 2000, The MDM2 RING-finger domain is required to promote p53 nuclear export, Nat Cell Biol, 2, 569, 10.1038/35023507

Boyd, 2000, An intact HDM2 RING-finger domain is required for nuclear exclusion of p53, Nat Cell Biol, 2, 563, 10.1038/35023500

Yu, 2000, MDM2-dependent ubiquitination of nuclear and cytoplasmic p53, Oncogene, 19, 5892, 10.1038/sj.onc.1203980

Xirodimas, 2001, Cocompartmentalization of p53 and Mdm2 Is a major determinant for Mdm2-mediated degradation of p53, Exp Cell Res, 270, 66, 10.1006/excr.2001.5314

Shirangi, 2002, Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage, FASEB J, 16, 420, 10.1096/fj.01-0617fje

Masdehors, 2000, Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes, Blood, 96, 269, 10.1182/blood.V96.1.269

Pariat, 1997, Proteolysis by calpains: a possible contribution to degradation of p53, Mol Cell Biol, 17, 2806, 10.1128/MCB.17.5.2806

Kubbutat, 1997, Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability, Mol Cell Biol, 17, 460, 10.1128/MCB.17.1.460

Gonen, 1997, On the involvement of calpains in the degradation of the tumor suppressor protein p53, FEBS Lett, 406, 17, 10.1016/S0014-5793(97)00225-1

Benetti, 2001, The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis, EMBO J, 20, 2702, 10.1093/emboj/20.11.2702

Fuchs, 1998, MEKK1/JNK signaling stabilizes and activates p53, Proc Natl Acad Sci USA, 95, 10541, 10.1073/pnas.95.18.10541

Fuchs, 1998, JNK targets p53 ubiquitination and degradation in nonstressed cells, Genes Dev, 12, 2658, 10.1101/gad.12.17.2658